Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Solid Biosciences Inc. - Common Stock
(NQ:
SLDB
)
4.160
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Solid Biosciences Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst
December 13, 2024
Wedbush initiates Solid Biosciences with an Outperform rating, citing the potential of SGT-003 for Duchenne muscular dystrophy and a robust cash runway.
Via
Benzinga
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
September 16, 2024
Via
Benzinga
SLDB Stock Earnings: Solid Biosciences Beats EPS for Q2 2024
August 13, 2024
SLDB stock results show that Solid Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
This Planet Fitness Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
June 24, 2024
Via
Benzinga
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
June 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 21, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 21, 2024
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy
June 20, 2024
The agency signed off on Elevidys for a broad population of children with the muscle-wasting disease.
Via
Investor's Business Daily
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
June 13, 2024
Sarepta is now just awaiting the FDA's decision on whether to fully approve its gene therapy, and for whom.
Via
Investor's Business Daily
Exposures
Product Safety
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
May 20, 2024
With the innovation space possibly getting overstretched, these biotech stocks to buy could benefit from a sector rotation.
Via
InvestorPlace
SLDB Stock Earnings: Solid Biosciences Meets EPS for Q1 2024
May 15, 2024
SLDB stock results show that Solid Biosciences met analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
May 10, 2024
Via
Benzinga
How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback
March 28, 2024
The company could follow Sarepta Therapeutics with a gene therapy for Duchenne muscular dystrophy.
Via
Investor's Business Daily
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
March 15, 2024
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQ: BLND) rose sharply during Friday’s session after the company reported...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
5 Value Stocks In The Healthcare Sector
February 26, 2024
Via
Benzinga
Top 4 Health Care Stocks You May Want To Dump In February
February 15, 2024
As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
February 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 30, 2024
Via
Benzinga
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 31, 2024
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on...
Via
Benzinga
Insiders Buying Solid Biosciences And 2 Other Stocks
January 16, 2024
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 09, 2024
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
January 01, 2024
Via
Benzinga
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 08, 2023
Shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) moved lower during Friday’s session following weak quarterly earnings.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 08, 2023
Via
Benzinga
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
December 08, 2023
Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 07, 2023
Via
Benzinga
What's Going On With Solid Biosciences Stock Today?
December 07, 2023
Solid Biosciences Inc. (NASDAQ: SLDB) shares traded higher on Thursday. The company announced that it received Fast Track Designation from the U.S.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 07, 2023
Via
Benzinga
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 07, 2023
Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.